Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AQST

Aquestive Therapeutics Inc

Dec 07 • 02:01PM ET

2.12

Dollar change +0.06
Percentage change 2.91	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	5.70%	Shs Outstand	66.77M	Perf Week	-5.78%
Market Cap	141.55M	Forward P/E	-	EPS next Y	-0.30	Insider Trans	0.00%	Shs Float	62.96M	Perf Month	23.98%
Income	-12.11M	PEG	-	EPS next Q	-0.09	Inst Own	34.31%	Short Float / Ratio	3.05% / 6.31	Perf Quarter	41.33%
Sales	48.06M	P/S	2.95	EPS this Y	88.84%	Inst Trans	-4.22%	Short Interest	1.92M	Perf Half Y	-1.40%
Book/sh	-1.54	P/B	-	EPS next Y	-138.67%	ROA	-21.76%	Target Price	6.33	Perf Year	135.50%
Cash/sh	0.37	P/C	5.68	EPS next 5Y	-	ROE	-	52W Range	0.72 - 2.69	Perf YTD	135.01%
Dividend	-	P/FCF	23.59	EPS past 5Y	-19.73%	ROI	-1868.98%	52W High	-21.19%	Beta	2.72
Dividend %	-	Quick Ratio	1.47	Sales past 5Y	-5.88%	Gross Margin	55.19%	52W Low	194.44%	ATR	0.18
Employees	130	Current Ratio	1.76	Sales Q/Q	13.43%	Oper. Margin	-45.58%	RSI (14)	56.56	Volatility	12.88% 8.87%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	86.57%	Profit Margin	-25.20%	Rel Volume	1.33	Prev Close	2.06
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 06 AMC	Payout	-	Avg Volume	304.25K	Price	2.12
Recom	1.00	SMA20	8.44%	SMA50	26.36%	SMA200	31.20%	Volume	286,370	Change	2.91%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$7
Apr-22-19	Initiated	H.C. Wainwright	Buy
Jan-03-19	Initiated	Lake Street	Buy	$14
Aug-20-18	Initiated	RBC Capital Mkts	Outperform	$23
Aug-20-18	Initiated	JMP Securities	Mkt Outperform	$29

Dec-05-23 08:00AM	Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Nov-29-23 09:55AM	Aquestive Therapeutics (AQST) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-27-23 12:00PM	Aquestive Therapeutics (AQST) Is Up 2.98% in One Week: What You Should Know (Zacks) -8.49%
09:40AM	Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? (Zacks)
Nov-16-23 12:00PM	Aquestive Therapeutics (AQST) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +8.18%
09:40AM	Loading…
Nov-10-23 09:40AM	Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:00AM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting (GlobeNewswire)
Nov-08-23 02:58PM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:55PM	Aquestive Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
05:54PM	Aquestive Therapeutics Inc (AQST) Reports 25% Year-Over-Year Growth in Year-to-Date Revenue (GuruFocus.com)
04:37PM	Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-23 08:00AM	Aquestive Therapeutics Completes $45 Million Debt Refinancing (GlobeNewswire) -6.49%
Nov-01-23 06:00PM	Aquestive Therapeutics (AQST) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Oct-31-23 08:00AM	Aquestive Therapeutics to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 6 and Host Conference Call on November 7 at 8:00 a.m. ET (GlobeNewswire)
Oct-24-23 06:00PM	Aquestive Therapeutics (AQST) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
06:15PM	Loading…
Oct-09-23 06:15PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why (Zacks)
08:00AM	Aquestive Therapeutics Provides Business Update (GlobeNewswire)
Oct-03-23 06:15PM	Aquestive Therapeutics (AQST) Stock Moves -0.71%: What You Should Know (Zacks)
Sep-27-23 06:15PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-21-23 12:24PM	Aquestive (AQST) Up on Reaffirming Anaphylm Development Pathway (Zacks)
Sep-20-23 09:04AM	Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm (epinephrine) Sublingual Film (GlobeNewswire) +11.76%
Sep-15-23 06:00PM	Aquestive Therapeutics (AQST) Gains As Market Dips: What You Should Know (Zacks)
Sep-13-23 06:15PM	Aquestive Therapeutics (AQST) Flat As Market Gains: What You Should Know (Zacks)
Sep-12-23 08:26AM	Aquestive's (AQST) Libervant Accepted for FDA Review, Stock Up (Zacks) +5.73%
Sep-11-23 08:00AM	Aquestive Therapeutics Receives FDA Acceptance of New Drug Application (NDA) for Libervant (diazepam) Buccal Film in Pediatric Patients and Assignment of Prescription Drug User Fee Act (PDUFA) Date (GlobeNewswire)
Aug-23-23 08:00AM	Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-11-23 07:08AM	Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) 11% loss last week hit both individual investors who own 60% as well as institutions (Simply Wall St.)
Aug-10-23 10:03AM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-07-23 05:40PM	Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Aquestive Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Loading…
04:01PM	Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-23 08:00AM	Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jul-27-23 07:00AM	Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Jul-25-23 04:01PM	Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET (GlobeNewswire)
08:00AM	Aquestive Therapeutics to Present Positive Topline Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at Aspen Allergy Conference (GlobeNewswire)
Jul-21-23 06:00PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jul-18-23 06:15PM	Aquestive Therapeutics (AQST) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jul-14-23 09:40AM	Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? (Zacks)
Jul-12-23 06:15PM	Aquestive Therapeutics (AQST) Gains But Lags Market: What You Should Know (Zacks)
Jul-06-23 08:00AM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at Global Food Allergy Prevention Summit (GlobeNewswire)
Jun-29-23 09:35AM	Down -31.17% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround (Zacks)
08:42AM	Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment (GlobeNewswire)
Jun-28-23 09:40AM	Are Medical Stocks Lagging Agios Pharmaceuticals (AGIO) This Year? (Zacks)
Jun-20-23 07:14PM	Alpine Immune Sciences, Inc. (ALPN) Soars 5.6%: Is Further Upside Left in the Stock? (Zacks) -5.09%
Jun-14-23 08:00AM	Investors in Aquestive Therapeutics (NASDAQ:AQST) have seen solid returns of 171% over the past year (Simply Wall St.)
Jun-12-23 09:40AM	Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year? (Zacks)
May-31-23 08:00AM	Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study (GlobeNewswire) +12.14%
May-26-23 09:40AM	Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? (Zacks)
May-11-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Aquestive Therapeutics (AQST) is a Great Choice (Zacks)
May-09-23 10:00AM	Best Momentum Stocks to Buy for May 9th (Zacks)
May-04-23 06:17AM	Aquestive Therapeutics First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.) +16.67%
May-02-23 06:15PM	Aquestive Therapeutics (AQST) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:13PM	Aquestive Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:31PM	Aquestive Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-26-23 10:02AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:00AM	Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Apr-25-23 10:01AM	Aquestive Therapeutics (AQST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) -5.88%
Apr-20-23 08:00AM	Aquestive Therapeutics Receives Conditional FDA Acceptance of Proprietary Name Anaphylm for Lead Candidate AQST-109 (Epinephrine Sublingual Film) (GlobeNewswire)
Apr-18-23 08:00AM	Aquestive Therapeutics to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 2 and Host Conference Call on May 3 at 8:00 a.m. ET (GlobeNewswire) -5.45%
Apr-17-23 07:18AM	There's No Escaping Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Muted Revenues Despite A 63% Share Price Rise (Simply Wall St.) +8.27%
Mar-29-23 08:30AM	Aquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant (diazepam) Buccal Film to Additional Global Markets (GlobeNewswire) +11.58%
Mar-08-23 11:43PM	Q4 2022 Aquestive Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 05:15PM	Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.55%
04:01PM	Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Business Update on Key 2023 Objectives (GlobeNewswire)
Mar-01-23 10:00AM	Assertio (ASRT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:00AM	Aquestive Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Feb-28-23 10:00AM	Aquestive Therapeutics (AQST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-22-23 08:00AM	Aquestive Therapeutics to Report Fourth Quarter 2022 Financial Results and Recent Business Highlights on March 7 and Host Conference Call on March 8 at 8:00 a.m. ET (GlobeNewswire)
Feb-21-23 08:00AM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting (GlobeNewswire)
Feb-13-23 10:31AM	Assertio (ASRT) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-27-23 05:51AM	When Will Aquestive Therapeutics, Inc. (NASDAQ:AQST) Breakeven? (Simply Wall St.)
Jan-06-23 08:00AM	Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives (GlobeNewswire)
Dec-22-22 08:00AM	Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film) (GlobeNewswire)
Nov-29-22 08:00AM	Aquestive Therapeutics Announces Publication of Crossover Food Effect Study of Diazepam Nasal Spray in Epilepsia (GlobeNewswire)
Nov-15-22 08:00AM	Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Nov-09-22 04:33PM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic Studies for AQST-109 (epinephrine sublingual film) at American Academy of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting (GlobeNewswire)
Nov-01-22 05:15PM	Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-27-22 09:05AM	Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc. (GlobeNewswire)
09:00AM	Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc. (GlobeNewswire)
Oct-24-22 08:00AM	Aquestive Therapeutics Announces Positive Decision in States Suboxone Antitrust Lawsuit on All Claims (GlobeNewswire)
Oct-19-22 08:00AM	Aquestive Therapeutics to Report Third Quarter 2022 Financial Results and Recent Business Highlights on November 1 and Host Conference Call on November 2 at 8:00 a.m. ET (GlobeNewswire) -6.85%
Oct-11-22 08:00AM	Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film (GlobeNewswire) +5.88%
Sep-28-22 12:14PM	Aquestive Inks Supply Pact For Its Seizure Treatment Covering European, Middle East Countries (Benzinga)
08:00AM	Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant (diazepam) Buccal Film for European and MENA Markets (GlobeNewswire)
Sep-27-22 09:35AM	Aquestive's AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction (Benzinga)
07:00AM	Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen® (GlobeNewswire)
Sep-12-22 04:01PM	Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board (GlobeNewswire)
Aug-31-22 04:02PM	Aquestive Therapeutics to Participate in Two Investor Conferences in September (GlobeNewswire)
08:00AM	Aquestive Therapeutics Receives FDA Tentative Approval for Libervant (diazepam) Buccal Film (GlobeNewswire)
Aug-10-22 04:50PM	Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space (GlobeNewswire) +12.50%
Aug-04-22 12:34PM	Pacira's (PCRX) Q2 Earnings Miss Estimates, Revenues Rise Y/Y (Zacks)
09:56AM	A number of insiders bought Aquestive Therapeutics, Inc. (NASDAQ:AQST) stock last year, which is great news for shareholders (Simply Wall St.)
12:30AM	Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-02-22 05:15PM	Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Jul-26-22 08:00AM	Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference (GlobeNewswire) -6.72%
Jul-20-22 08:00AM	Aquestive Therapeutics to Report Second Quarter 2022 Financial Results and Recent Business Highlights on August 2 and Host Conference Call on August 3 at 8:00 a.m. ET (GlobeNewswire) +6.22%
Jul-11-22 08:00AM	Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film (GlobeNewswire) +8.29%
Jun-16-22 07:32AM	Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies (Benzinga) -17.80%

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AQST

Aquestive Therapeutics Inc

Upgrade your FINVIZ experience